Skip to content
Wholesale trade
KZActiveBIN 150140020285
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "WEDEL PHARMA"

Director
Сауытбаев Руслан Бақытжанұлы
Incorporated
26.01.2015
Address
Алматы ул. МАНАШ ҚОЗЫБАЕВ, 8, Н.П. 54
РНН
600400688684

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "WEDEL PHARMA"
BIN
150140020285
Status
Active
Director
Сауытбаев Руслан Бақытжанұлы
Registration date
26.01.2015
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Алматы ул. МАНАШ ҚОЗЫБАЕВ, 8, Н.П. 54

In government contracts over 2 years

VAT payer
Yes, since 01.03.2015
КАТО
751410000
РНН
600400688684
КФС
Собственность совместных предприятий с иностранным участием
КСЕ
Нефинансовые корпорации под иностранным контролем – ОПП
Company size
Малые предприятия
Employees
от 11 до 15 чел.

Has changed

Procurement role
Поставщик

Activities

2
46461primary

Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями

Secondary

  • 46180Деятельность агентов, специализирующихся на оптовой торговле отдельными видами товаров или группами товаров, не включенными в другие группировки
Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
208M
2025
137.7M-52%
2024
286M-31%
2023
412.5M-8%
2022
447.8M+953%
2021
42.5M
·208M
2026year to date
-52%137.7M
2025
-31%286M
2024
-8%412.5M
2023
+953%447.8M
2022
·42.5M
2021
2026
Tax paid208,012,922 ₸
Penalty144,758 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid137,741,905 ₸
Penalty86,046 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid286,043,524 ₸
Penalty714,967 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid412,518,955 ₸
Penalty146,398 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid447,776,089 ₸
Penalty1,743,943 ₸
Fine12,116,743 ₸
VAT refund0 ₸
2021
Tax paid42,533,549 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • СР

    Сауытбаев Руслан Бақытжанұлы

    Director

Former directors

  • ТДТИМЕРБУЛАТОВ ДАНИЯР РАШИДОВИЧ
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "WEDEL PHARMA" (BIN 150140020285) is an active legal entity in Алматы, registered in 2015 (11 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 8, 2026: 60 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 274,997,225 ₸. Automated screening of open registries found no risk indicators for "WEDEL PHARMA". Director on record — Сауытбаев Руслан Бақытжанұлы. Data current as of November 8, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.